Ultrasound-driven plant lipid vesicles amplify oncolytic virotherapy in colorectal cancer
Journal of Controlled Release · 2026-11 · 399 · 115368
DOI: 10.1016/j.jconrel.2026.115368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Baoyi Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Prov…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oncolytic Virotherapy, Porphyrins, Lipids. Die Arbeit nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Sichuan Academy of Social Sciences.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a highly aggressive malignancy, and its treatment with oncolytic virotherapy is hindered by multiple delivery barriers and delayed therapeutic kinetics. To address these challenges, we developed a plant lipid-based vesicular system (P-M@Ce6-OVs) co-encapsulating oncolytic viruses (OVs) and sonosensitizer chlorin e6 (Ce6), enabling ultrasound (US)-guided, spatiotemporally controlled delivery to deep colorectal tumors. Under US exposure, the system enhanced mucus infiltration, tumor penetration, and lysosomal escape, while activating sonodynamic therapy to rapidly induce tumor ablation and compensate delayed viral oncolysis. In CRC mouse models, rectal administration of P-M@Ce6-OVs with US exposure achieved a 10.3-fold reduction in tumor burden compared with the control (without treatment), markedly outperforming monotherapies. Importantly, combination with αPD-L1 not only suppressed primary CRC and re-challenged tumors mimicking metastatic relapse, but also induced durable systemic immune protection. This triple combination further potentiated systemic and mucosal antitumor immunity, restoring cytotoxic T-cell function and reinforcing humoral and gut-localized immune responses. Notably, this treatment reshaped gut microbiota by enriching nucleoside-metabolizing bacteria (e.g., Lactobacillus taiwanensis) and altering microbial metabolic profiles, including the pathways related to pyrimidine catabolism and arachidonic acid oxidation. These microbiota and metabolic changes were associated with immune remodeling and tumor suppression. Collectively, this platform integrated US-enabled delivery, sonodynamic activation, and microbiome remodeling to synergistically suppress CRC and re-challenged tumor progression, amplifying virotherapy and antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic…
- Department of Biotechnology, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Beibei, Chongqing 400715, China.
- The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Chongqing Medical University, Yuzhong, Chongqing 400016, China.
- 3Bs Research Group I3Bs - Research Institute on Biomaterials, Biodegradables, and Biomimetics, University of Minho Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Ba…
- The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Chongqing Medical University, Yuzhong, Chongqing 400016, China. Electronic address: lv.peng@cqmu.edu.cn.
- Department of Biotechnology, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Beibei, Chongqing 400715, China. Electronic address: xxshi7@swu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- Sichuan Academy of Social Sciences
- National Key Research and Development Program of China
Zitieren
APA
Li, B., Li, X., Deng, Y., Luo, Y., Huang, Y., She, D., Li, H., Ji, S., Liu, G., Wang, Y., Zu, M., Kundu, S. C., Zhang, P., Lv, P., Shi, X., & Xiao, B. (2026). Ultrasound-driven plant lipid vesicles amplify oncolytic virotherapy in colorectal cancer. Journal of Controlled Release, 399, 115368. https://doi.org/10.1016/j.jconrel.2026.115368
Vancouver
Li B, Li X, Deng Y, Luo Y, Huang Y, She D, et al. Ultrasound-driven plant lipid vesicles amplify oncolytic virotherapy in colorectal cancer. Journal of Controlled Release. 2026;399:115368. doi:10.1016/j.jconrel.2026.115368
BibTeX
@article{Li2026,
author = {Li, Baoyi and Li, Xiaoyan and Deng, Yuntian and Luo, Yuting and Huang, Yu and She, Dan and Li, Huiling and Ji, Shuhui and Liu, Ga and Wang, Yajun and Zu, Menghang and Kundu, Subhas C and Zhang, Peijing and Lv, Peng and Shi, Xiaoxiao and Xiao, Bo},
title = {Ultrasound-driven plant lipid vesicles amplify oncolytic virotherapy in colorectal cancer},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115368},
doi = {10.1016/j.jconrel.2026.115368}
}
EUVIMED